Wells Fargo 21st Annual Healthcare Conference September 9, 2026 3:45 PM EDTCompany ParticipantsRoop Lakkaraju - ...

Revenue estimates for Bio-Rad Laboratories Inc (NYSE:BIO) have declined from $2.58 billion to $2.58 billion for the full year 2024 and declined from $2.67 billion to $2.65 billion for 2025 over the ...

Great. We're going to go ahead and kick it off. I'm Tycho Peterson from the Life Science team. I'm pleased to have Bio-Rad with us today. We've got Roop. Yes. First of all, Tycho, and Matt, thanks for ...

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Alice N. Schwartz ...

Upslope Capital Management, an investment management company, released its third-quarter investor letter. A copy of the letter can be downloaded here. The third quarter was a strong one for the fund ...

The stock price of Bio-Rad Laboratories (NYSE: BIO), a life science research and clinical diagnostic products company, has seen a 10% rise over the last twenty-one trading days, while it is up 30% ...

View Bio-Rad Laboratories, Inc. Class A BIO stock quote prices, financial information, real-time forecasts, and company news from CNN.